Osteoarthritis, Knee Clinical Trial
Official title:
Combined Prospective / Retrospective, Open, Non-randomized, Non-interventional Post Market Clinical Follow-Up of the BPK-S Integration System (Co28Cr6Mo) Used for Primary Total Knee Replacement
Verified date | March 2020 |
Source | Peter Brehm GmbH |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Patients who received a total knee endoprosthesis BPK-S Integration between 2011 and 2013
will be invited to participate in this PMCF study provided sufficient source data
documentation is available regarding preoperative, intraoperative and early postoperative
follow-up assessments.
Only patients providing written informed consent prior to any study data collection can take
part in the study.
Preoperative, intraoperative and early postoperative data (3 months, 1 year and 2 years after
implantation) will be collected retrospectively. Additional long-term follow-up of one visit
(year 7 after implantation) will be documented prospectively.
Only parameters assessed in clinical standard care for follow-up (implant control) visits
will be collected for this PMCF study.
Radiological assessment of the implanted prosthesis will only be conducted if medically
indicated according to the investigator. No additional study related assessment will be
performed.
Only anonymized data will be used in this observational study to protect patient privacy. No
personally identifiable information will be collected.
Status | Completed |
Enrollment | 62 |
Est. completion date | March 2, 2020 |
Est. primary completion date | March 2, 2020 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients that received a total primary knee endoprosthesis BPK-S Integration (Co28Cr6Mo) between 2011 and 2013 - Patients that agree to participate and give written informed consent to the anonymized retrospective and prospective data collection within the study Exclusion Criteria: No study specific exclusion criteria are defined for this PMCF study. |
Country | Name | City | State |
---|---|---|---|
Belgium | Centre Hospitalier de Wallonie picarde - CHwapi A.S.B.L | Tournai | |
Belgium | Medical Center Tournai | Tournai |
Lead Sponsor | Collaborator |
---|---|
Peter Brehm GmbH | P.R.I.S.M.A.-CRO |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Patient relevant benefit after 5 years | improvement of KSS-Score by at least one category as compared to preoperative basic assessment | 7 years | |
Secondary | Safety parameters | Incidents that require reporting to the competent authority and complications during and after surgery as documented in source documentation | 7 years | |
Secondary | Patient relevant benefit as measured by American Knee Society Score | improvement of KSS-Score as compared to preoperative basic assessment | 1 year | |
Secondary | Implant Loosening Number | Number of implant loosening due to quality issues with the implant | 7 years | |
Secondary | Implant Loosening Reason | Reason for implant loosening due to quality issues with the implant | 7 years | |
Secondary | Revision Number | Number of revisions, if required | 7 years | |
Secondary | Revision Reason | Reason for revision, if required | 7 years | |
Secondary | Surgery Parameters | Evaluation of surgery time as documented in the surgical report | Day 0 = day of surgery | |
Secondary | Surgery Parameters | Evaluation of tourniquet time as documented in the surgical report | Day 0 = day of surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03895489 -
Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses
|
N/A | |
Completed |
NCT03660943 -
A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain
|
Phase 3 | |
Completed |
NCT04531969 -
Comparison of Outpatient and Inpatient Spa Therapy
|
N/A | |
Completed |
NCT02848027 -
Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment
|
Phase 3 | |
Completed |
NCT05160246 -
The Instant Effect of Kinesiology Taping in Patients With Knee OA
|
N/A | |
Recruiting |
NCT06080763 -
Biomechanics and Clinical Outcomes in Responders and Non-Responders
|
||
Completed |
NCT03643588 -
The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain
|
N/A | |
Active, not recruiting |
NCT05100225 -
Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis
|
Phase 2 | |
Active, not recruiting |
NCT04061733 -
New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis
|
N/A | |
Completed |
NCT04051489 -
A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
|
||
Recruiting |
NCT05546541 -
Epidemiology and Nutrition
|
||
Recruiting |
NCT05447767 -
Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg
|
Phase 2 | |
Not yet recruiting |
NCT04448106 -
Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis
|
Phase 2 | |
Not yet recruiting |
NCT03225911 -
Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis
|
N/A | |
Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
Completed |
NCT05703087 -
Positive Cueing in Knee Arthroplasty.
|
N/A | |
Not yet recruiting |
NCT06042426 -
Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population
|
Phase 4 | |
Terminated |
NCT02615522 -
Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration
|
||
Completed |
NCT02901964 -
Effect of Strengthening the Hip Abductor in Patients With Knee Osteoarthritis: Randomized Controlled Trial
|
N/A | |
Not yet recruiting |
NCT02865174 -
Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty
|
Phase 4 |